These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16528611)
1. An analysis of unclassified missense substitutions in human BRCA1. Tavtigian SV; Samollow PB; de Silva D; Thomas A Fam Cancer; 2006; 5(1):77-88. PubMed ID: 16528611 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. Tavtigian SV; Deffenbaugh AM; Yin L; Judkins T; Scholl T; Samollow PB; de Silva D; Zharkikh A; Thomas A J Med Genet; 2006 Apr; 43(4):295-305. PubMed ID: 16014699 [TBL] [Abstract][Full Text] [Related]
3. Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Tavtigian SV; Byrnes GB; Goldgar DE; Thomas A Hum Mutat; 2008 Nov; 29(11):1342-54. PubMed ID: 18951461 [TBL] [Abstract][Full Text] [Related]
4. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. Abkevich V; Zharkikh A; Deffenbaugh AM; Frank D; Chen Y; Shattuck D; Skolnick MH; Gutin A; Tavtigian SV J Med Genet; 2004 Jul; 41(7):492-507. PubMed ID: 15235020 [TBL] [Abstract][Full Text] [Related]
5. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Chenevix-Trench G; Healey S; Lakhani S; Waring P; Cummings M; Brinkworth R; Deffenbaugh AM; Burbidge LA; Pruss D; Judkins T; Scholl T; Bekessy A; Marsh A; Lovelock P; Wong M; Tesoriero A; Renard H; Southey M; Hopper JL; Yannoukakos K; Brown M; Easton D; Tavtigian SV; Goldgar D; Spurdle AB; Cancer Res; 2006 Feb; 66(4):2019-27. PubMed ID: 16489001 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes. Akbari MR; Zhang S; Fan I; Royer R; Li S; Risch H; McLaughlin J; Rosen B; Sun P; Narod SA J Med Genet; 2011 Nov; 48(11):783-6. PubMed ID: 21965345 [TBL] [Abstract][Full Text] [Related]
7. Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. Spurdle AB; Lakhani SR; Healey S; Parry S; Da Silva LM; Brinkworth R; Hopper JL; Brown MA; Babikyan D; Chenevix-Trench G; Tavtigian SV; Goldgar DE; J Clin Oncol; 2008 Apr; 26(10):1657-63. PubMed ID: 18375895 [TBL] [Abstract][Full Text] [Related]
8. Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants. Vallée MP; Di Sera TL; Nix DA; Paquette AM; Parsons MT; Bell R; Hoffman A; Hogervorst FB; Goldgar DE; Spurdle AB; Tavtigian SV Hum Mutat; 2016 Jul; 37(7):627-39. PubMed ID: 26913838 [TBL] [Abstract][Full Text] [Related]
9. Characterization of common BRCA1 and BRCA2 variants. Deffenbaugh AM; Frank TS; Hoffman M; Cannon-Albright L; Neuhausen SL Genet Test; 2002; 6(2):119-21. PubMed ID: 12215251 [TBL] [Abstract][Full Text] [Related]
10. In silico analysis of missense substitutions using sequence-alignment based methods. Tavtigian SV; Greenblatt MS; Lesueur F; Byrnes GB; Hum Mutat; 2008 Nov; 29(11):1327-36. PubMed ID: 18951440 [TBL] [Abstract][Full Text] [Related]
11. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany. Meyer P; Voigtlaender T; Bartram CR; Klaes R Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098 [TBL] [Abstract][Full Text] [Related]
12. Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity. Walker LC; Whiley PJ; Couch FJ; Farrugia DJ; Healey S; Eccles DM; Lin F; Butler SA; Goff SA; Thompson BA; Lakhani SR; Da Silva LM; ; Tavtigian SV; Goldgar DE; Brown MA; Spurdle AB Hum Mutat; 2010 Jun; 31(6):E1484-505. PubMed ID: 20513136 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252 [TBL] [Abstract][Full Text] [Related]
14. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai]. Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400 [TBL] [Abstract][Full Text] [Related]
15. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997 [TBL] [Abstract][Full Text] [Related]
16. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658 [TBL] [Abstract][Full Text] [Related]
17. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain. Esteban Cardeñosa E; Bolufer Gilabert P; Palanca Suela S; Oltra Soler S; Barragán González E; Velasco Sampedro E; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Breast Cancer Res Treat; 2008 Nov; 112(1):69-73. PubMed ID: 18060494 [TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Zhi X; Szabo C; Chopin S; Suter N; Wang QS; Ostrander EA; Sinilnikova OM; Lenoir GM; Goldgar D; Shi YR Hum Mutat; 2002 Dec; 20(6):474. PubMed ID: 12442274 [TBL] [Abstract][Full Text] [Related]
19. Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Mathe E; Olivier M; Kato S; Ishioka C; Hainaut P; Tavtigian SV Nucleic Acids Res; 2006; 34(5):1317-25. PubMed ID: 16522644 [TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance. Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]